There has been increasing interest and progress in the regenerative therapies field, including studies focusing on the generation of insulin-producing cells (IPCs) derived from embryonic stem cells, the umbilical cord, and various adult tissues, such as adipose tissue [3,4], since insulin administration does not prevent the long-term complications of diabetes. This evidence concerns the gene INS and diabetes mellitus.